Showing results (141-150 of 177) with videos related to

Sort By:
Pageof 18
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2019
FGFR1 Amplification Mediates Endocrine Resistance but Retains TORC Sensitivity in Metastatic Hormone Receptor-Positive (HR+) Breast CancerJoshua Z Drago, Luigi Formisano, Dejan Juric, et al.
Journal of the National Cancer Institute|October 24, 2017
An ERBB1-3 Neutralizing Antibody Mixture With High Activity Against Drug-Resistant HER2+ Breast Cancers With ERBB Ligand OverexpressionLuis J Schwarz, Katherine E Hutchinson, Brent N Rexer, et al.
Oncotarget|May 26, 2016
Everolimus induces Met inactivation by disrupting the FKBP12/Met complexLucia Raimondo, Valentina D'Amato, Alberto Servetto, et al.
Journal for Immunotherapy of Cancer|January 12, 2025
Early assessment of IL8 and PD1+ Treg predicts response and guides treatment monitoring in cemiplimab-treated cutaneous squamous cell carcinomaDaniela Esposito, Fabiana Napolitano, Daniela Claudia Maresca, et al.
BMC Cancer|June 4, 2026
Real-world outcomes of second-line pembrolizumab in urothelial carcinoma: a multicenter analysis from the Campania Oncological Network (ROC)Rosa Tambaro, Gabriele Calvanese, Andrea Muto, et al.
Oncoimmunology|August 29, 2024
Overexpression of CCL-20 and CXCL-8 genes enhances tumor escape and resistance to cemiplimab, a programmed cell death protein-1 (PD-1) inhibitor, in patients with locally advanced and metastatic cutaneous squamous cell carcinomaVincenzo De Falco, Stefania Napolitano, Renato Franco, et al.
Scientific Reports|August 26, 2017
Urokinase-type plasminogen activator receptor (uPAR) expression enhances invasion and metastasis in RAS mutated tumorsConcetta Di Mauro, Ada Pesapane, Luigi Formisano, et al.
The Oncologist|November 17, 2025
Best therapeutic approach in metastatic hormone-sensitive prostate cancer based on disease volume: a systematic review and network meta-analysisFabrizio Di Costanzo, Chiara Mercinelli, Alessio Signori, et al.
ESC Heart Failure|April 1, 2022
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patientsAlessandra Cuomo, Valentina Mercurio, Gilda Varricchi, et al.
Clinical Genitourinary Cancer|April 14, 2024
Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry StudyVeronica Mollica, Francesco Massari, Marco Maruzzo, et al.
Pageof 18